Bcl-2 and therefore may explain the synergism between Myc and Bcl-2 observed in certain tumor cells.
Expression of the c-myc proto-oncogene is strongly implicated in the control of cell growth and proliferation. Expression of c-myc is necessary and in some cases sufficient for entry into the S phase of the cell cycle (4, 13, 14, 37) , whereas shutoff of c-myc expression is associated with quiescence or cellular differentiation. Correspondingly, addition of growth factors to quiescent cells leads to a transient increase in the level of c-myc expression, and deprivation of growth factors leads to virtually undetectable levels of the RNA and protein. In addition, c-myc expression is frequently deregulated in neoplasias and is often implicated in their genesis (for reviews, see references 4a, 10, 11, 26, and 43) . The mechanism(s) by which Myc can influence cell growth is as yet unknown but may include its activity as a transcriptional regulator (3, 13, 22, 23a, 24, 31a) , its ability to bind growth suppressors such as the retinoblastoma gene product (38) , and its ability to induce DNA replication (8, 21) .
Paradoxically, despite the apparent importance of Myc in the induction of cell proliferation, expression of Myc has recently been linked to the induction of cell death (4, 14, 40) . In two of these reports (4, 14) , cell death was accelerated or induced by inappropriate expression of Myc. These studies demonstrated that ectopic expression of Myc under conditions where Myc is not normally expressed (i.e., in growth factor withdrawal or serum deprivation) resulted in cell death by apoptosis, a process typified by nuclear condensation and DNA fragmentation into oligonucleosomal fragments (for reviews, see references 51 to 53 and 56).
To further study Myc-induced apoptosis, we examined the effect of coexpression of the proto-oncogene bc12 in Rat la fibroblasts constitutively expressing high levels of Myc. These cells have been shown to undergo apoptosis when deprived of serum (14) . We chose to examine the effect of * Corresponding author.
Bcl-2 on the basis of its ability to inhibit apoptosis in many hematopoietic systems. bc12 was discovered as a result of its translocation to the immunoglobulin heavy-chain enhancer in the t(14;18) translocation present in more than 80% of human follicular lymphomas (7, 9) . These neoplasias are characterized by an accumulation of mature resting B cells presumed to result from a block of apoptosis which would normally cause turnover of these cells; transgenic mice expressing Bcl-2 under the control of the E,u enhancer similarly develop follicular lymphomas which have a high risk of developing into malignant lymphomas (20, 27, 44) . Bcl-2 expression has been shown to exhibit protective effects on cells under a variety of conditions, including glucocorticoid-and cyclic AMP-induced apoptosis of T and B cells (2) and growth factor withdrawal-induced apoptosis in hematopoietic cells (5, 20, 48) . Additionally, Bcl-2 expression has been demonstrated to reduce growth factor requirements in fibroblasts (34) and to increase cell survival during ethanol and heat shocks (46) . We report here that Bcl-2 expression is sufficient to inhibit apoptosis induced by Myc expression in serum-starved fibroblasts. coding sequence and was subcloned into the EcoRI site of the retroviral vector pMV7 (Fig. 1B and C) (23) . These plasmids, in addition to the parental pMV7, were individually stably transfected into 42 cells by the calcium phosphate coprecipitation method (17) . Selection for cells expressing the virus-encoded genes was begun after 48 h by 1:10 dilution of the cells into medium containing 1,000 ,ug of G418 per ml (for pMV7 transfections) or 400 ,ug of hygromycin B per ml (for pMV12 transfections). Two days following initiation of selection, antibiotic concentrations were reduced to 500 ,ug of G418 per ml and 200 ,ug of hygromycin B per ml. After 1 week of selection, surviving cells were pooled and used to produce retrovirus.
MATERIALS AND METHODS
The Rat la cell line was infected for 4 h in 10 p,g of Polybrene per ml with the pMV12-Myc retrovirus by standard methods (6) . Infected cells were diluted 1:10 after 48 h and selected for 2 days in medium containing 400 ,ug of hygromycin B per ml; they were then maintained in medium containing 200 ,ug of hygromycin B per ml. Resistant clones were selected and expanded as clonal cell lines; a single line, designated RAiMH3-la, was used in this study. RAiMH3-la cells were infected with pMV7-Bcl2 retrovirus or with pMV7 retrovirus as a control to generate the polyclonal cell lines Rat lalmyc/bcl2 and Rat lalmyc/neo, respectively. Cells from each line were pooled to eliminate clonal variation. All cells were maintained in 5% CO2 in Dulbecco's modified E4 medium supplemented with 10% fetal calf serum, 100 U of penicillin G per ml, and 100 ,ug of streptomycin sulfate per ml. Rat la/myc/bcl2 and Rat lalmyclneo cells were maintained in medium supplemented with 200 ,ug of hygromycin B per ml and 500 ,ug of G418 per ml.
RNA isolation and Northern (RNA) analysis. Total cellular RNA was isolated from proliferating cells by the guanidinium isothiocyanate method followed by centrifugation through a CsCl cushion (47) . Electrophoresis of 15 ,ug of total RNA through a 1% agarose-2.2 M formaldehyde gel, transfer to nitrocellulose, and hybridization to [a-32P]dCTPlabeled probes were performed as described previously (50) . The 1.4-kb EcoRI-HindIII fragment of pGEMMYC (50) was used for random-primed labeling (Multiprime; Amersham) of a human c-Myc cDNA probe, a 950-bp EcoRI fragment of pGEMBcl2 was used to synthesize a human Bcl-2 cDNA probe, and a 1.2-kb XbaI fragment containing rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA (a gift of H. Singh, University of Chicago) was used for control probe synthesis.
Induction and analysis of apoptosis. A total of 106 cells from each cell line were plated on 100-mm-diameter plates 15 h prior to starvation for serum, at which time the medium was replaced with Dulbecco's modified E4 medium containing only penicillin and streptomycin. Cells were examined microscopically, and representative fields were photographed at each time point to observe morphological changes and the extent of cell death as represented by the relative numbers of floating and adherent cells. Additionally, at each time point, floating cells were collected by aspiration of the medium and a 10-ml phosphate-buffered saline (PBS) wash, followed by centrifugation for 5 min in a clinical centrifuge. Cells were washed in Ca2"-Mg2+-free PBS containing 1 mM EDTA, pelleted, and lysed by resuspension in 1 mM EDTA-0.6% sodium dodecyl sulfate. Sodium chloride was added to 1 M, and the solution was mixed by gentle inversion and incubated at 4°C overnight. Following centrifugation for 20 min in a microcentrifuge at 4°C, low-molecular-weight DNA was ethanol precipitated from the supernatant. DNA was analyzed for fragmentation by electrophoresis in 1.5% agarose in Tris-acetate-EDTA buffer, stained with ethidium bromide, and photographed under UV illumination.
Determination of cell viability. Triplicate cultures of 104 cells from each cell line were plated on 60-mm-diameter plates 15 h prior to serum deprivation and were treated as described above. At each time point, floating cells were collected by centrifugation of the aspirated medium and a 5-ml PBS wash and were resuspended in 1 ml of PBS. Adherent cells were trypsinized, collected in 10 ml of PBS, centrifuged, and resuspended in 1 ml of PBS. Numbers of viable and nonviable cells from each time point were determined by trypan blue exclusion.
Cell cycle analysis. Subconfluent proliferating cells and cells starved of serum for 48 h (as described above) were washed twice in PBS and then scraped in 1 ml of PBS. The cells were fixed in 50% ethanol-50% PBS, digested with RNase A, and stained with 100 ,ug of propidium iodide per ml. Cell cycle profiles and distributions were determined by flow-cytometric analysis of 104 cells by using the LysisII program on a FACScan flow cytometer (Becton-Dickinson). (Fig. 2) . Retrovirally expressed c-Myc mRNA is present at high levels in the derived cell lines Rat lalmyclneo and Rat la/myclbcl2 but not in Rat la cells ( Fig. 2A) , and Bcl-2 mRNA is similarly expressed at high levels in only the Rat lalmyclbcl2 cells (Fig. 2B) . When (Fig. 3, 0 h, middle and bottom panels) and by the ability of the cells to grow in soft agarose (data not shown).
Starvation of the parental Rat la cells resulted in a decrease in refractility and a more pronounced flattening. This flattening, coupled with completion of mitosis of cells already committed to the cell cycle at the initiation of starvation, resulted in the appearance of continued cell proliferation (Fig. 3, 48 h, top panel). Some cell death did occur during starvation, although this fraction was minor compared with the proportion of cells that remained adherent (Fig. 4A) . Constitutive expression of c-myc, however, resulted in a rapid induction of detachment and cell death which increased with prolonged starvation, reaching a 15-fold increase after 48 h (Fig. 3 [middle panels] and 4A). The dying cells underwent a transition from being tightly attached to loosely attached to detached from the tissue culture plate. This effect was much more apparent and dramatic in cells expressing c-myc alone than in the parental Rat la cells or in cells coexpressing c-myc and bcl2 (Fig. 3) mine whether these cells were in fact undergoing apoptosis, we analyzed genomic DNA isolated from the floating cells at each time point by agarose gel electrophoresis. These cells represent a population of dead cells which have completely detached from the plate. Figure 5 demonstrates observable fragmentation in all cell lines at 24 h of starvation, with fragmentation in Rat lalmyclneo cells most prominent. This contrast is more pronounced after 48 h. Although some fragmentation is present in Bcl-2-expressing cells, the degree of fragmentation is comparable to that of the control cells. As previously reported (14) , DNA is fragmented into oligonucleosomal fragments in serum-starved Myc-expressing cells, but here we observe that expression of Bcl-2 reduces the level of fragmentation to that of cells not expressing Myc. The extent of fragmentation observed reflects the number of floating dead cells in each case. Cellular detachment is a late event in apoptosis (14) , but, although only the nonadherent cells were analyzed for DNA fragmentation by this assay, fragmentation in apoptosis has been shown to be a rapidly induced event in many systems. Accordingly, DNA fragmentation is also occurring in the adherent-cell population as observed by electrophoresis of low-molecular-weight DNA isolated from adherent Myc-expressing serum-starved cells (21a) Fig. 3 ), fractionated by electrophoresis in a 1.5% agarose gel, and visualized by ethidium bromide staining and UV fluorescence. Lanes: 1, 4, and 7 (lanes A), DNA from Rat la cells; 2, 5, and 8 (lanes B), DNA from Rat la myc/neo cells; 3, 6, and 9 (lanes C), DNA from Rat la myclbcl2 cells following 10 h (lanes 1 to 3), 24 h (lanes 4 to 6), and 48 h (lanes 7 to 9) of serum starvation; 10, X DNA (digested with HindIII) and (X174 DNA (digested with HaeIII) molecular size markers. 48 sion of Myc or of Myc and Bcl-2 had no significant effect on cell cycle distribution in proliferating cells when compared with Rat la cells ( Fig. 6a to c This peak represents cells with <2c DNA content; specifically, these are cells with fragmented DNA (1, 30) . These cells constituted 47.0% ± 0.2% of total Rat lalmyclneo cells (Table 1 ) and demonstrate apoptosis in the adherent-cell population. This peak also developed in the serum-starved Rat la and Rat lalmyc/bcl2 cell lines ( Fig. 6d and f) but to a lesser degree (12.8% + 0.5% for Rat la cells and 27.1% + 0.2% for Rat la/myc/bcl2 cells [ Table 1 ]), in agreement with our data on fragmented DNA in the floating-cell population observed by agarose gel electrophoresis. Thus, coexpression of bc12 with c-myc reduced the Myc-mediated induction of DNA fragmentation observed during serum deprivation without blocking entry into the cell cycle, providing further evidence that Bcl-2 expression can block apoptosis induced by enforced high-level expression of Myc in serum-starved fibroblasts.
DISCUSSION
In this report we observe that constitutive overexpression of Myc in serum-deprived Rat la fibroblasts induces apoptosis and demonstrate that expression of Bcl-2 is sufficient to inhibit this cell death. This effect was observed both at the level of light microscopy of cells in culture and by the degree of DNA fragmentation as monitored by agarose gel electrophoresis and DNA content analysis. Induction of apoptosis by Myc and inhibition by Bcl-2 were distinctly observable by 24 h of serum starvation, and protection by Bcl-2 persisted for at least as long as the time it took for all Rat lalmyc/neo cells to die (approximately 1 week). Furthermore, Bcl-2 coexpression enabled serum-deprived cells to enter and traverse the cell cycle with a distribution similar to that for proliferating cells.
These studies confirm and extend the work of Evan et al. (14) describing the induction of apoptosis in quiescent fibroblasts by constitutive overexpression of c-Myc. Similarly, c-Myc has been demonstrated to accelerate induction of apoptosis during interleukin-3 (IL-3) withdrawal from an IL-3-dependent myeloid cell line (4) and blockage of c-Myc expression by antisense oligonucleotides was sufficient to inhibit apoptosis induced by anti-CD3 treatment of a hybridoma cell line (40) . These observations, coupled with evidence that Myc is essential for cell replication, lead to a paradox: how is Myc capable of regulating two processes with distinctly opposite outcomes, cell growth and cell death? One possibility is that a factor present in serum generates an intracellular signal which activates a pathway complementing Myc and activating cell growth. This signal may represent the initiation of specific gene induction or protein modification which produces or activates other proteins to act in concert with Myc to induce cell growth.
However, in the absence of this second pathway (i.e., under conditions of growth factor deprivation), Myc induces cell death. In several systems, induction of apoptosis has been demonstrated to be dependent on new RNA and protein synthesis. Evidence that Myc can serve as a sequencespecific DNA-binding protein and transcriptional activator implicates activation of specific genes as a mechanism by which Myc can induce either proliferation or apoptosis. Indeed, activation of apoptosis by Myc has been shown to be dependent on regions of Myc that were also shown to be essential for transformation (14) , and these domains have recently been demonstrated to be essential for trans activation (3, 22) . However, although Myc has been shown to activate the transcription of specific genes (13, 31) , no connection has been established between these genes and genes induced during apoptosis.
We chose to overexpress Bcl-2 to examine its effect on Myc-induced apoptosis on the basis of its ability to inhibit apoptosis in a variety of hematopoietic cell lines and tissues. This effect has been extensively demonstrated in promyeloid, pre-B-cell, and pro-B-cell lines induced to undergo apoptosis by growth factor withdrawal (5, 20, 48) or glucocorticoid treatment (2) and in T cells of transgenic animals (44) . Bcl-2 expression has also been found to reduce the growth factor requirements of NIH 3T3 fibroblasts for DNA synthesis (33) , although the level of DNA synthesis obtained was lower than that in cells treated with growth factors. Similarly, expression of Bcl-2 in B-lymphoblastoid cell lines resulted in an increased tolerance to stresses of serum deprivation, ethanol and methotrexate treatment, and heat shock (46) . The protective effect of Bcl-2 does not appear to be a result of altering cell cycle progression since we did not observe a change in cell cycle profile attributable to expression of Bcl-2, and other studies have reported that Bcl-2 expression has no effect on cell cycle progression in pro-B cells (20) and does not block establishment of quiescence in serum-starved NIH 3T3 cells (34) . Although we observed that expression of Bcl-2 enhanced cell survival during Mycinduced cell cycle progression in serum-deprived fibroblasts, coexpression of Myc and Bcl-2 did not lead to IL-3-independent proliferation in FDC-P1 myeloid cells (48) and did not block phorbol ester-induced growth arrest in the human B-cell leukemia cell line 380 (25) . One explanation for this difference is that enforced Myc expression may not be sufficient for cell cycle progression in all cell lines and that Bcl-2 expression maintains cell viability without promoting growth. Although many hematopoietic cell lines and at least one fibroblast cell line can be protected from apoptosis by Bcl-2 expression, this phenomenon may not be universal, since Bcl-2 overexpression was not sufficient to make an IL-2-dependent T-cell line or an IL-6-dependent myeloma line interleukin independent (20) .
The ability of Bcl-2 expression to repress Myc-induced apoptosis in serum-starved fibroblasts suggests that this form of apoptosis shares a common mechanism with apoptosis induced in hematopoietic lines as described above. How Bcl-2 actually inhibits apoptosis is unclear; the protein has been localized to the inner mitochondrial membrane and has been reported to have no kinase or GTP-binding activity (20) . It is normally constitutively expressed throughout the cell cycle (35) , although its expression is induced following mitogenic activation of peripheral blood lymphocytes (36) . One suggested role of Bcl-2 is as a regulator of intracellular Ca2+ concentration, since the mitochondrion is a major store of cytosolic Ca2+ and Ca2+ acts both as a second messenger in the signal pathway from growth factor receptors to the nucleus and as an inducer of apoptosis (2) .
Activation of a cell death pathway by inappropriate expression of Myc may have evolved as a mechanism to prevent development of neoplasias from cells with deregulated Myc expression (see also reference 14). That is, cells which aberrantly express high levels of Myc without the activation of complementary pathways by signaling from growth factors would be selectively destroyed instead of proliferating. This would represent a rapid and efficient mechanism for protecting an organism from unchecked cell growth, since Myc expression alone enables cells to enter the cell cycle (13, 14) . According to this model, for tumors to develop, additional mutations or deregulations which would either activate a complementary pathway or block apoptosis would be required.
It is notable that Myc overexpression occurs in many neoplasias which are evidently able to escape the programmed cell death pathway. In at least one instance, that of malignant lymphomas derived from the t(14;18) translocation, induction of apoptosis by overexpression of c-Myc may be blocked by the high levels of Bcl-2 expressed as a result of bc12 translocation to the immunoglobulin heavy-chain enhancer. In this lymphoma, deregulation of c-myc is preceded by deregulation of bc12 and genesis of an indolent follicular lymphoma, which then clonally develops into a malignant lymphoma as a single cell acquires a c-myc translocation as well (27) . It is conceivable that this particular type of lymphoma can develop only if the bc12 translocation occurs first, since the c-myc translocation may induce the cells to undergo cell death. A similar situation exists in Burkitt's lymphomas, in which Myc is overexpressed as a result of translocation of c-myc to an immunoglobulin allele (11, 43) , an event which is highly associated with prior infection with Epstein-Barr virus. Interestingly, the EpsteinBarr virus gene BHRFI encodes a protein with significant homology to Bcl-2 (9) and may therefore protect cells from apoptosis upon acquiring translocation of a c-myc allele. In addition, the latently expressed Epstein-Barr virus protein LMP-1 induces Bcl-2 expression and inhibits apoptosis (16, 18, 19) . Finally, the cooperativity of c-myc and bc12 in immortalization of pre-B cells (48) , tumorigenicity of T cells (32) , transformation of human B-lymphoblastoid cell lines (29) , and transformation of rat embryo fibroblasts with an activated ras (33) (15, 54) ; and small-cell lung carcinomas, which exhibit L-myc amplification and mutant p53 genes (28, 45) . It is possible that in tumors or tumor cell lines in which myc is aberrantly expressed, the apoptosis pathway must be disrupted for the cells to survive when the availability of growth factors is limited (e.g., inadequate neovascularization). One mechanism appears to be deregulation and overexpression of the bc12 gene. Potentially, p53 mutations or deletions constitute a second mechanism for escaping apoptosis induced by Myc deregulation. This hypothesis would implicate p53 mutation as a requisite predecessor to c-myc overexpression to allow for the cells to progress to a malignant state while avoiding apoptosis. It still remains to be determined, however, whether Myc-mediated apoptosis actually involves induction of p53, which would then activate apoptosis and/or cell cycle withdrawal, thereby suppressing tumor development.
